Demographic and situation-specific guides. Each addresses what's different about GLP-1 therapy for your specific situation.
Men over 40
CV risk demographic. Sarcopenia. Testosterone. Alcohol pattern.
Women over 40
Hormonal shifts. Sleep disruption. Body composition.
Perimenopause
5–10 yr window of metabolic vulnerability. Visceral adiposity.
Postmenopause
Bone density. Sarcopenia. CV risk.
Post-bariatric
Weight regain after sleeve/RYGB.
Busy professionals
Time-poor; what fits the schedule.
Seniors 65+
Sarcopenia. Polypharmacy. Functional considerations.
PCOS patients
Insulin resistance. Fertility implications.